Ventas (VTR) Up 2.2% Since Last Earnings Report: Can It Continue?

Core Viewpoint - Ventas shares have increased by approximately 2.2% since the last earnings report, outperforming the S&P 500, but there are concerns about whether this positive trend will continue leading up to the next earnings release [1]. Estimates Movement - Estimates for Ventas have trended downward over the past month, indicating a negative outlook [2]. VGM Scores - Ventas has a subpar Growth Score of D, a strong Momentum Score of A, and a Value Score of D, placing it in the bottom 40% for the value investment strategy. The overall aggregate VGM Score for the stock is D [3]. Outlook - The overall direction of estimate revisions for Ventas has been downward, with a net zero change in magnitude. The stock holds a Zacks Rank of 3 (Hold), suggesting an expectation of in-line returns in the coming months [4]. Industry Performance - Ventas is part of the Zacks REIT and Equity Trust - Other industry. Healthpeak, a competitor in the same industry, has seen a slight gain of 0.4% over the past month. Healthpeak reported revenues of $697.99 million for the quarter ended December 2024, reflecting a year-over-year increase of 26.1$0.46 per share, which represents a year-over-year change of 2.2%. The Zacks Consensus Estimate for Healthpeak has increased by 0.3% over the last 30 days, and it also holds a Zacks Rank of 3 (Hold) with a VGM Score of D [6].